A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

May 28, 2019

Primary Completion Date

July 8, 2021

Study Completion Date

July 22, 2021

Conditions
Ureter Injury
Interventions
DRUG

IS-001

intravenous injection of IS-001 investigational drug

DRUG

No treatment

no drug injection

Trial Locations (3)

20037

George Washington University Hospital, Washington D.C.

78758

St.David's Medical Center, Austin

79902

Las Palmas Medical Center, El Paso

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Intuitive Surgical

INDUSTRY

NCT03937505 - A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy | Biotech Hunter | Biotech Hunter